Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| 10-K | 10-K | 10-K | 10-K | S-1/A |
Revenues | 1.4 | 3.0 | 82.7 | 0.0 | 0.0 |
Revenue growth | -54.4% | -96.3% | | | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 1.4 | 3.0 | 82.7 | 0.0 | 0.0 |
Gross margin | 100.0% | 100.0% | 100.0% | | |
Selling, general and administrative [+] | 300.7 | 367.7 | 138.5 | 84.0 | 8.9 |
General and administrative | | | | | 8.9 |
Research and development | 246.4 | 172.7 | 99.9 | 70.3 | 41.0 |
Other operating expenses | -246.4 | -295.7 | -99.9 | -154.4 | |
EBITDA [+] | | | | | -47.7 |
EBITDA growth | 23.8% | 333.2% | | -100.0% | |
EBITDA margin | -21670.9% | -7979.5% | -67.5% | | |
Depreciation and amortization | | | | | 2.2 |
EBIT [+] | -299.3 | -241.7 | -55.8 | 0.0 | -49.9 |
EBIT growth | 23.8% | 333.2% | | -100.0% | |
EBIT margin | -21670.9% | -7979.5% | -67.5% | | |
Non-recurring items [+] | | 123.0 | | | |
In-process research & development | | 123.0 | | | |
Interest income | 8.8 | 0.8 | 3.4 | 8.8 | |
Interest income | 8.8 | 0.8 | 3.4 | 8.8 | |
Other income (expense), net | 0.0 | 0.0 | 0.0 | -84.1 | 1.1 |
Pre-tax income | -290.5 | -363.9 | -52.4 | -75.3 | -48.8 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -290.5 | -363.9 | -52.4 | -75.3 | -48.8 |
Net margin | -21036.1% | -12012.9% | -63.4% | | |
|
Basic EPS [+] | ($2.59) | ($3.82) | ($1.23) | ($21.82) | ($19.63) |
Growth | -32.3% | 211.0% | -94.4% | 11.2% | |
Diluted EPS [+] | ($2.59) | ($3.82) | ($1.23) | ($21.82) | ($19.63) |
Growth | -32.3% | 211.0% | -94.4% | 11.2% | |
|
Shares outstanding (basic) [+] | 112.2 | 95.1 | 42.6 | 3.5 | 2.5 |
Growth | 18.0% | 123.2% | 1135.2% | 38.8% | |
Shares outstanding (diluted) [+] | 112.2 | 95.1 | 42.6 | 3.5 | 2.5 |
Growth | 18.0% | 123.2% | 1135.2% | 38.8% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|